Extent of allergic inflammation depends on intermittent versus continuous sensitization to house dust mite

Inhal Toxicol. 2017 Feb;29(3):106-112. doi: 10.1080/08958378.2017.1311389. Epub 2017 Apr 16.

Abstract

Objective: House dust mite (HDM) exposure is used to model experimental asthma in mice. However, a direct comparison of inflammatory responses following continuous versus intermittent HDM exposure has not been reported. Therefore, we investigated whether the HDM dose at sensitization or challenge affects extent of inflammation in mice that were either continuously or intermittently sensitized with HDM.

Materials and methods: C57BL/6 mice received either 10 continuous exposures with 10 μg HDM per exposure or two intermittent HDM exposures over a period of two weeks and were subsequently challenged by three instillations with HDM during the third week. For the intermittent model, mice were sensitized with 1 or 10 μg HDM and challenged on three consecutive days with 1 or 10 μg HDM. Inflammatory cells in the bronchoalveolar lavage fluid and epithelial cell hyperplasia and mucous cell metaplasia were quantified.

Results: Significantly higher levels of inflammation and mucous cell metaplasia were observed when mice were sensitized intermittently compared with continuously. Intermittent sensitization and challenge with 10 μg HDM caused maximum inflammation, mucous cell metaplasia, and epithelial cell hyperplasia. However, sensitization with 1 μg HDM only also showed increased inflammation when challenged with 10 μg HDM.

Discussion: These findings suggest major differences in adaptive immunity, depending on the sensitization protocol.

Conclusions: Because of significant differences, the HDM sensitization protocol should be carefully considered when designing studies to investigate the underlying mechanisms of immunity in mouse models of asthma.

Keywords: House dust mite; allergic sensitization; asthma; inflammation; mucous cell metaplasia.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adaptive Immunity
  • Allergens / administration & dosage*
  • Allergens / immunology
  • Animals
  • Bronchoalveolar Lavage Fluid / immunology
  • Epithelial Cells / pathology
  • Hyperplasia / pathology
  • Hypersensitivity / immunology*
  • Hypersensitivity / pathology
  • Inflammation / immunology*
  • Inflammation / pathology
  • Lung / immunology
  • Male
  • Mice, Inbred C57BL
  • Pyroglyphidae / immunology*

Substances

  • Allergens